Variant report
Variant | nsv972202 |
---|---|
Chromosome Location | chr8:112905099-112914431 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73326207 | chr8:112905108-112905109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566601932 | chr8:112905169-112905170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192603243 | chr8:112905261-112905262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577119912 | chr8:112905275-112905276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559606268 | chr8:112905342-112905343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539871821 | chr8:112905346-112905347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556420777 | chr8:112905349-112905350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143136795 | chr8:112905444-112905445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547499012 | chr8:112905449-112905450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528235963 | chr8:112905455-112905456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541515326 | chr8:112905480-112905481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183803971 | chr8:112905516-112905517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561220466 | chr8:112905523-112905524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188912445 | chr8:112905561-112905562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540729272 | chr8:112905608-112905609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564248505 | chr8:112905646-112905647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530146732 | chr8:112905657-112905658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192398894 | chr8:112905739-112905740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184252239 | chr8:112905740-112905741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549747199 | chr8:112905798-112905799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs320505 | chr8:112905802-112905803 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs114565096 | chr8:112905806-112905807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs118151054 | chr8:112905808-112905809 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552418981 | chr8:112905813-112905814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534822477 | chr8:112905824-112905825 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370215625 | chr8:112905836-112905837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115017596 | chr8:112905875-112905876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs320506 | chr8:112905883-112905884 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs147054105 | chr8:112905896-112905897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10156229 | chr8:112905907-112905908 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs558672196 | chr8:112905908-112905909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548306732 | chr8:112906029-112906030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528302076 | chr8:112906075-112906076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138169685 | chr8:112906114-112906115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568048555 | chr8:112906133-112906134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537080211 | chr8:112906247-112906248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572538392 | chr8:112906290-112906291 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541656496 | chr8:112906305-112906306 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs320507 | chr8:112906336-112906337 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs577700385 | chr8:112906341-112906342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543558073 | chr8:112906486-112906487 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576876815 | chr8:112906494-112906495 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563245368 | chr8:112906496-112906497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs528898080 | chr8:112906513-112906514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549254651 | chr8:112906539-112906540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539756108 | chr8:112906550-112906551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559637045 | chr8:112906553-112906554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188573364 | chr8:112906572-112906573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551590167 | chr8:112906611-112906612 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571369741 | chr8:112906612-112906613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:112901600-112906600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr8:112901800-112907200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:112905800-112907800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr8:112906200-112907000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr8:112906600-112907600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:112906600-112907600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr8:112906600-112907600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr8:112907200-112909200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr8:112909800-112911200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:112910000-112912600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |